References
- Kazim M, Garrity JA. Orbital radiation therapy for thyroid eye disease. J Neuroophthalmol 2012;32(2):172–176
- Dolman PJ, Rath S. Orbital radiotherapy for thyroid eye disease. Curr Opin Ophthalmol 2012;23(5):427–432
- Ng CM, Yuen HK, Choi KL, et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves’ ophthalmopathy: a preliminary study. Hong Kong Med J 2005;11:322–330
- Bartalena L, Baldeschi L, Dickinson A, et al. Consensus statement of the European Group on Graves’ Orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol 2008;158:273–285
- Kazim M, Trokel S, Moore S. Treatment of acute Graves’ orbitopathy. Ophthalmology 1991;98:1443–1448
- Prummel MF, Mourits MP, Blank L, et al. Randomized double blind trial of prednisone versus radiotherapy in Graves’ ophthalmopathy. Lancet 1993;342:949–954
- Behbehani R, Sergott RC, Savino PJ. Orbital radiotherapy for thyroid-related orbitopathy. Curr Opin Ophthalmol 2004;15(6):479–482
- Nygaard B, Specht L. Transitory blindness after retrobulbar irradiation of Graves’ ophthalmopathy [letter]. Lancet 1998;351:725–726